Sodium iodide symporter-targeted gene therapy in glioblastoma.
作者信息
Nicola Juan Pablo, LaRocca Christopher J
机构信息
Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba, Argentina.
Clinical Biochemistry and Immunology Research Center - National Scientific and Technical Research Council (CIBICI-CONICET), Córdoba, Argentina.
出版信息
Mol Ther Oncolytics. 2023 Jan 4;28:44-45. doi: 10.1016/j.omto.2022.12.004. eCollection 2023 Mar 16.
Abstract
摘要
相似文献
1
Sodium iodide symporter-targeted gene therapy in glioblastoma.针对胶质母细胞瘤的碘化钠同向转运体靶向基因治疗。
Mol Ther Oncolytics. 2023 Jan 4;28:44-45. doi: 10.1016/j.omto.2022.12.004. eCollection 2023 Mar 16.
2
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma.双重表皮生长因子受体（EGFR）和转铁蛋白受体（TfR）靶向基因转移用于胶质母细胞瘤的碘化钠同向转运体基因治疗
Mol Ther Oncolytics. 2022 Nov 3;27:272-287. doi: 10.1016/j.omto.2022.10.013. eCollection 2022 Dec 15.
3
Selective sodium iodide symporter () genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes.由表皮生长因子受体靶向脂质多聚体介导的胶质母细胞瘤选择性钠碘同向转运体（）基因治疗。
Mol Ther Oncolytics. 2021 Oct 30;23:432-446. doi: 10.1016/j.omto.2021.10.011. eCollection 2021 Dec 17.
4
Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.人钠/碘同向转运体基因启动子在甲状腺乳头状癌细胞系和正常甲状腺细胞中的差异调控
Endocrinology. 2001 Aug;142(8):3369-79. doi: 10.1210/endo.142.8.8344.
5
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.碘化钠同向转运体（NIS）作为诊疗基因：其在新型成像模式和非病毒基因治疗中的新作用。
EJNMMI Res. 2022 May 3;12(1):25. doi: 10.1186/s13550-022-00888-w.
6
Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.碘化钠同向转运体在肝癌发生的癌前阶段及人类胆管癌中表达。
Gastroenterology. 2007 Apr;132(4):1495-503. doi: 10.1053/j.gastro.2007.01.044. Epub 2007 Jan 26.
7
Methylation of sodium iodide symporter promoter correlated with aggressiveness and metastasis in papillary thyroid carcinoma: a meta-analysis.碘化钠转运体启动子甲基化与甲状腺乳头状癌的侵袭性和转移相关：一项荟萃分析
Int J Clin Exp Med. 2015 Jul 15;8(7):10731-8. eCollection 2015.
8
Characterisation of the purified human sodium/iodide symporter reveals that the protein is mainly present in a dimeric form and permits the detailed study of a native C-terminal fragment.纯化的人钠/碘同向转运体的特性表明，该蛋白主要以二聚体形式存在，并允许对天然C末端片段进行详细研究。
Biochim Biophys Acta. 2011 Jan;1808(1):65-77. doi: 10.1016/j.bbamem.2010.08.013. Epub 2010 Aug 23.
9
[Sodium iodide symporter in physiology and diseases -- the current state of knowledge].[碘化钠同向转运体在生理与疾病中的研究现状]
Endokrynol Pol. 2007 Nov-Dec;58(6):512-21.
10
The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and Mutation.甲状腺乳头状癌中放射性碘难治性、钠/碘同向转运体表达与突变之间的关联
Onco Targets Ther. 2021 Jun 29;14:3959-3969. doi: 10.2147/OTT.S308910. eCollection 2021.
本文引用的文献
1
Structural insights into the mechanism of the sodium/iodide symporter.钠离子/碘转运体的结构机制研究进展
Nature. 2022 Dec;612(7941):795-801. doi: 10.1038/s41586-022-05530-2. Epub 2022 Dec 14.
2
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma.双重表皮生长因子受体（EGFR）和转铁蛋白受体（TfR）靶向基因转移用于胶质母细胞瘤的碘化钠同向转运体基因治疗
Mol Ther Oncolytics. 2022 Nov 3;27:272-287. doi: 10.1016/j.omto.2022.10.013. eCollection 2022 Dec 15.
3
Selective sodium iodide symporter () genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes.由表皮生长因子受体靶向脂质多聚体介导的胶质母细胞瘤选择性钠碘同向转运体（）基因治疗。
Mol Ther Oncolytics. 2021 Oct 30;23:432-446. doi: 10.1016/j.omto.2021.10.011. eCollection 2021 Dec 17.
4
A Novel SLC5A5 Variant Reveals the Crucial Role of Kinesin Light Chain 2 in Thyroid Hormonogenesis.一种新型 SLC5A5 变体揭示了驱动蛋白轻链 2 在甲状腺激素生成中的关键作用。
J Clin Endocrinol Metab. 2021 Jun 16;106(7):1867-1881. doi: 10.1210/clinem/dgab283.
5
Current practice in patients with differentiated thyroid cancer.分化型甲状腺癌患者的现行治疗方法。
Nat Rev Endocrinol. 2021 Mar;17(3):176-188. doi: 10.1038/s41574-020-00448-z. Epub 2020 Dec 18.
6
Engineering precision nanoparticles for drug delivery.工程化精准纳米颗粒用于药物递送。
Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4.
7
Tumor microenvironment affects exogenous sodium/iodide symporter expression.肿瘤微环境影响外源性钠/碘同向转运体的表达。
Transl Oncol. 2021 Jan;14(1):100937. doi: 10.1016/j.tranon.2020.100937. Epub 2020 Nov 17.
8
Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity.高级别神经胶质瘤的纳米医学研究的临床前小鼠模型的比较研究：重现血脑屏障异质性的重要性。
Theranostics. 2020 May 15;10(14):6361-6371. doi: 10.7150/thno.46468. eCollection 2020.
9
Breaking Down the Barriers to Precision Cancer Nanomedicine.破解精准癌症纳米医学的障碍。
Trends Biotechnol. 2017 Feb;35(2):159-171. doi: 10.1016/j.tibtech.2016.07.006. Epub 2016 Aug 1.
10
Glioblastoma: pathology, molecular mechanisms and markers.胶质母细胞瘤：病理学、分子机制和标志物。
Acta Neuropathol. 2015 Jun;129(6):829-48. doi: 10.1007/s00401-015-1432-1. Epub 2015 May 6.
Zotero 插件